Varicella mortality: trends before vaccine licensure in the United States, 1970-1994
- PMID: 10915066
- DOI: 10.1086/315714
Varicella mortality: trends before vaccine licensure in the United States, 1970-1994
Abstract
We examined varicella deaths in the United States during the 25 years before vaccine licensure and identified 2262 people who died with varicella as the underlying cause of death. From 1970 to 1994, varicella mortality declined, followed by an increase. Mortality rates were highest among children; however, adult varicella deaths more than doubled in number, proportion, and rate per million population. Despite declining fatality rates, in 1990-1994, adults had a risk 25 times greater and infants had a risk 4 times greater of dying from varicella than did children 1-4 years old, and most people who died of varicella were previously healthy. Varicella deaths are now preventable by vaccine. Investigation and reporting of all varicella deaths in the United States is needed to accurately document deaths due to varicella, to improve prevention efforts, and to evaluate the vaccine's impact on mortality.
Similar articles
-
Decline in mortality due to varicella after implementation of varicella vaccination in the United States.N Engl J Med. 2005 Feb 3;352(5):450-8. doi: 10.1056/NEJMoa042271. N Engl J Med. 2005. PMID: 15689583
-
Near elimination of varicella deaths in the US after implementation of the vaccination program.Pediatrics. 2011 Aug;128(2):214-20. doi: 10.1542/peds.2010-3385. Epub 2011 Jul 25. Pediatrics. 2011. PMID: 21788222
-
One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?Pediatrics. 2006 Jun;117(6):e1070-7. doi: 10.1542/peds.2005-2085. Pediatrics. 2006. PMID: 16740809
-
Varicella vaccination of children in the United States: assessment after the first decade 1995-2005.J Clin Virol. 2005 Jun;33(2):89-95; discussion 96-8. doi: 10.1016/j.jcv.2005.02.003. J Clin Virol. 2005. PMID: 15911422 Review.
-
Successes and remaining challenges after 10 years of varicella vaccination in the USA.Expert Rev Vaccines. 2006 Apr;5(2):295-302. doi: 10.1586/14760584.5.2.295. Expert Rev Vaccines. 2006. PMID: 16608428 Review.
Cited by
-
Immunity to Varicella Zoster Virus in Healthcare Workers: A Systematic Review and Meta-Analysis (2024).Vaccines (Basel). 2024 Sep 6;12(9):1021. doi: 10.3390/vaccines12091021. Vaccines (Basel). 2024. PMID: 39340051 Free PMC article. Review.
-
Connecting the dots: spots on the skin, weakness within.Infection. 2024 Aug;52(4):1645-1646. doi: 10.1007/s15010-024-02227-8. Epub 2024 Mar 13. Infection. 2024. PMID: 38480643 Free PMC article. No abstract available.
-
COVID-19 Vaccines in Children.J Clin Med. 2023 Dec 23;13(1):87. doi: 10.3390/jcm13010087. J Clin Med. 2023. PMID: 38202094 Free PMC article. Review.
-
Global Prevalence of Varicella-Associated Complications: A Systematic Review and Meta-Analysis.Infect Dis Ther. 2024 Jan;13(1):79-103. doi: 10.1007/s40121-023-00899-7. Epub 2023 Dec 19. Infect Dis Ther. 2024. PMID: 38117427 Free PMC article.
-
Varicella Zoster vaccination in hemodialysis patients: The state of the art.Hum Vaccin Immunother. 2023 Dec 15;19(3):2286689. doi: 10.1080/21645515.2023.2286689. Epub 2023 Nov 27. Hum Vaccin Immunother. 2023. PMID: 38010087 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

